Mining giant Teck Resources (TSX:TECKA) will take a 9.9 per cent stake in critical metals explorer Metal Energy (TSXV:MERG), granting it exposure to a highly-prospective portfolio in Manitoba and ...

Micron Technology (NASDAQ:MU) will exit its Crucial consumer business, ending sales of Crucial-branded products.

Cronos Group (TSX:CRON) will acquire Netherlands-based CanAdelaar, the largest adult-use cannabis company in Europe.

It may still be a bit premature to declare 2026 a banner year for the stock market. After all, the past year has been full of surprises: no meaningful economic growth, high prices, strained household ...

Context for investors: While BC is a global centre of alkalic porphyry systems, similar alkalic suites also occur in other regions (e.g., Australia). Miner Mountain’s setting within BC’s Quesnel belt ...

Toronto, Ontario--(Newsfile Corp. - November 24, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a ...

The world’s concerted push towards environmental sustainability often masks the green energy transition’s glacial pace, with renewables expected to grow from 3.5 per cent of the global market in 2024 ...

Equinox Gold (TSX/NYSE:EQX) achieves commercial production at its 100-per-cent-owned Valentine gold mine in Newfoundland & Labrador, Canada.

Toronto, Ontario-- (Newsfile Corp. - November 10, 2025) - Theralase® Technologies Inc. (TSXV:TLT) (OTCQB:TLTFF) (" Theralase® " or the " Company "), a clinical stage pharmaceutical pioneering light, ...

(2025-10-29 | TSX:AEM) AGNICO EAGLE REPORTS THIRD QUARTER 2025 RESULTS - RECORD ADJUSTED NET INCOME WITH ANOTHER QUARTER OF STRONG PRODUCTION; FINANCIAL POSITION FURTHER STRENGTHENED BY REPAYMENT OF ...

The global shift towards environmentalism is one of the strongest long-term tailwinds an investor can gain exposure to, making clean technology stocks a worthwhile consideration. There are three ...

This peer-reviewed publication provides strong support that Ruvidar® is more effective in the treatment of HSV-1 than either Acyclovir® or Metformin®, even without ...